- Report
- February 2024
- 75 Pages
France
From €4586EUR$4,750USD£3,883GBP
- Report
- April 2023
- 60 Pages
China
From €4586EUR$4,750USD£3,883GBP
- Report
- April 2023
- 120 Pages
Asia Pacific
From €4586EUR$4,750USD£3,883GBP
- Report
- April 2023
- 81 Pages
Sweden
From €4586EUR$4,750USD£3,883GBP
- Report
- April 2023
- 70 Pages
Spain
From €4586EUR$4,750USD£3,883GBP
- Report
- April 2023
- 65 Pages
India
From €4586EUR$4,750USD£3,883GBP
- Report
- April 2023
- 80 Pages
Italy
From €4586EUR$4,750USD£3,883GBP
- Report
- April 2023
- 85 Pages
South Korea
From €4586EUR$4,750USD£3,883GBP
- Report
- April 2023
- 110 Pages
Germany
From €4586EUR$4,750USD£3,883GBP
From €4586EUR$4,750USD£3,883GBP
- Report
- April 2023
- 70 Pages
Brazil
From €4586EUR$4,750USD£3,883GBP
- Report
- January 2022
- 75 Pages
South Africa
From €4586EUR$4,750USD£3,883GBP
- Report
- January 2022
- 78 Pages
Saudi Arabia
From €4586EUR$4,750USD£3,883GBP
- Report
- August 2020
- 70 Pages
Australia
From €3138EUR$3,250USD£2,657GBP
- Report
- August 2020
- 90 Pages
Japan
From €3138EUR$3,250USD£2,657GBP
- Report
- August 2020
- 70 Pages
Chile
From €3138EUR$3,250USD£2,657GBP
- Report
- June 2020
- 75 Pages
Argentina
From €4586EUR$4,750USD£3,883GBP
- Report
- May 2020
- 60 Pages
United Kingdom
From €4586EUR$4,750USD£3,883GBP
- Report
- March 2020
- 75 Pages
United States
From €4586EUR$4,750USD£3,883GBP
- Report
- May 2018
- 83 Pages
Europe
From €3717EUR$3,850USD£3,148GBP
Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more